Clinical trial · Interventional
Study Comparing Satisfaction of Hospitalized Patients Receiving Invasive Care for Cancer Treatment, With Snoezelen Session Versus Standard Care
Study Comparing Satisfaction of Hospitalized Patients Receiving Invasive Care for Cancer Treatment, With Snoezelen Session Versus Standard Care (SNOEZELEN)
NCT04783363CI-TRIAL-00070044SNOEZELENcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a monocentric, comparative, open-label, randomized, crossover study enrolling patients hospitalized in Strasbourg Europe Cancerology Institute, receiving repeated invasive care for cancer treatment. The purpose of this study is to compare the satisfaction of patients, regarding their perception of care, with or without Snoezelen session.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Snoezelen session | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Arm A
- description
- * Visit 1: with Snoezelen session before invasive care * Visit 2: standard care (=without Snoezelen session) before invasive care
- interventionNames
- Other: Snoezelen session
- type
- EXPERIMENTAL
- label
- Arm B
- description
- * Visit 1: standard care (=without Snoezelen session) before invasive care * Visit 2: with Snoezelen session before invasive care
- interventionNames
- Other: Snoezelen session
Primary outcomes (2)
- measure
- Patient satisfaction regarding their perception of care quality (with or without Snoezelen session) at Visit 1
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients treated for cancer and hospitalized for invasive care * Two programmed hospitalization for repeated care * Patients receiving one of the following invasive care: Huber needle application (transfusion, parenteral nutrition), complex wound dressing, intrathecal chemotherapy, ascites fluid or pleural puncture * Patients must be ≥ 18 years old * Performance Status ≤ 3 * Absence of psychiatric disorder impairing follow-up * Ability to speak, understand, write and read French * Signed informed consent from the patient * Affiliation to social security system Exclusion Criteria: * Patients presenting infectious symptoms requiring isolation * Patients \< 18 years old or patients ≥ 18 years old under supervision * Patients placed under judicial protection or guardianship * Women that are pregnant or breast-feeding
References
Publications (0)
Data not yet available
No reference posted for this study.